Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


University of New South Wales

Latest From University of New South Wales

Clinical Edge

Brief summaries of recent advances in device research and clinical trials, including an implantable sensor designed to measure cancer progression and treatment, new findings on angiogenesis-suppressing genes that protect Down's syndrome patients from cancer, research that implacates two inflammation-related proteins in breast cancer outcomes, and stem-cell implanted contact lenses that repair corneal damage.

Medical Device

Recent Tech Transfer Deals (11/07)

Our monthly update on technology transfer deals--licensing agreements between companies and universities or other research institutions--in the fields of life sciences, including pharmaceuticals, medical devices, in vitro diagnostics and research/analytical instrumentation and reagents.

Deals Update

A roundup of recent medtech strategic alliances, mergers & acquisitions and financings.

Medical Device

The Garvan Institute of Medical Research

The Garvan Institute of Medical Research became an autonomous research institute in 1984. Sponsored research accounts for one-quarter of Garvan's $14 million 1998 operating income. Going forward, it expects its income to derive approximately one-third from grants, one-third from donations, and one third from commercial activities. The bulk of current revenues from commercial activities come from Eli Lilly, Bristol-Myers, and Merck & Co.

BioPharmaceutical Asia Pacific
See All

Company Information

  • Industry
  • Academic and Research Institutions